
BioLine Rx (NASDAQ:BLRX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-16. Here's what investors need to know before the announcement.
Analysts estimate that BioLine Rx will report an earnings per share (EPS) of $-0.14.

BioLine Rx (NASDAQ:BLRX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-16. Here's what investors need to know before the announcement.
Analysts estimate that BioLine Rx will report an earnings per share (EPS) of $-0.14.